At the time of writing, Wave Life Sciences Ltd [WVE] stock is trading at $11.94, up 2.40%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WVE shares have gain 4.10% over the last week, with a monthly amount drifted -9.48%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wave Life Sciences Ltd [NASDAQ: WVE] stock has seen the most recent analyst activity on October 16, 2024, when Raymond James upgraded its rating to a Strong Buy but kept the price target unchanged to $22 for it. On September 19, 2024, B. Riley Securities initiated with a Buy rating and assigned a price target of $11 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $10 on September 09, 2024. Wells Fargo initiated its recommendation with a Overweight and recommended $11 as its price target on May 15, 2024. Leerink Partners upgraded its rating to Outperform for this stock on December 19, 2023, and upped its price target to $12. In a note dated July 05, 2023, Raymond James initiated an Outperform rating and provided a target price of $7 on this stock.
For the past year, the stock price of Wave Life Sciences Ltd fluctuated between $3.50 and $16.74. Currently, Wall Street analysts expect the stock to reach $22.14 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $11.94 at the most recent close of the market. An investor can expect a potential return of 85.43% based on the average WVE price forecast.
Analyzing the WVE fundamentals
According to Wave Life Sciences Ltd [NASDAQ:WVE], the company’s sales were 53.61M for trailing twelve months, which represents an -115.60% plunge. Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at -2.84%, Pretax Profit Margin comes in at -2.66%, and Net Profit Margin reading is -2.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -2.51 and Total Capital is -0.81. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.52 points at the first support level, and at 11.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.19, and for the 2nd resistance point, it is at 12.43.
Ratios To Look Out For
It is important to note that Wave Life Sciences Ltd [NASDAQ:WVE] has a current ratio of 1.90. As well, the Quick Ratio is 1.90, while the Cash Ratio is 1.82. Considering the valuation of this stock, the price to sales ratio is 33.97, the price to book ratio is 12.51.
Transactions by insiders
Recent insider trading involved BOLNO PAUL, President and CEO, that happened on Nov 25 ’24 when 50000.0 shares were sold. Officer, PAUL BOLNO completed a deal on Nov 25 ’24 to buy 50000.0 shares. Meanwhile, President and CEO BOLNO PAUL sold 51234.0 shares on Nov 15 ’24.
